ANGIODYNAMICS

Manufacturer adverse-event records for ANGIODYNAMICS come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 1996–2026 · thin-book · elevated Death-code · balanced

Volume signature

ANGIODYNAMICS is a thinner MAUDE footprint

ANGIODYNAMICS accounts for 3,627 FDA MAUDE reports (#433 of 443, thin-book tercile). Death-coded event_type share is 2.10% (elevated); Injury share 26.7% (balanced).

What the volume reading shows for ANGIODYNAMICS

The standout signal for ANGIODYNAMICS is filing volume: 3,627 adverse-event reports in FDA MAUDE (#433 of 443, thin-book). Death-coded event_type share sits at 2.10% (elevated).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 2,508 (69.1% of event_type total). Peak single-year volume reaches 344 reports across 28 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

3,627
Total Reports
76
Event-type Death
967
Injury Reports
20
Device Types

Event Types

Malfunction 2,508 (69.1%)
Injury 967 (26.7%)
Death 76 (2.1%)
Other 64 (1.8%)
12 (0.3%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,379 (63.6%)
Required Intervention 671 (17.9%)
Other 366 (9.8%)
Hospitalization 87 (2.3%)
R 79 (2.1%)
Death 79 (2.1%)
O 24 (0.6%)
Life Threatening 14 (0.4%)
Disability 13 (0.3%)
H 12 (0.3%)
L 10 (0.3%)
S 7 (0.2%)
Congenital Anomaly 1 (0.0%)

Yearly Trend

96
1996: 1
97
1997: 2
98
1998: 4
02
2002: 7
03
2003: 1
04
2004: 6
05
2005: 7
06
2006: 5
07
2007: 10
08
2008: 22
09
2009: 38
10
2010: 74
11
2011: 159
12
2012: 157
13
2013: 173
14
2014: 200
15
2015: 303
16
2016: 344
17
2017: 339
18
2018: 256
19
2019: 165
20
2020: 288
21
2021: 279
22
2022: 219
23
2023: 274
24
2024: 203
25
2025: 90
26
2026: 1